{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:06:16Z","timestamp":1794254776081,"version":"4.9.0"},"reference-count":4,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2704103"],"award-info":[{"award-number":["2022YFC2704103"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Cervical cancer ranks as the fourth most common malignancy in women globally.\n                      <jats:sup>1<\/jats:sup>\n                      For early stage disease, radical hysterectomy with pelvic lymphadenectomy remains the standard surgical approach. The LACC trial revealed that minimally invasive surgery (MIS) was associated with inferior oncologic outcomes compared with open surgery,\n                      <jats:sup>2<\/jats:sup>\n                      with this discrepancy largely attributed to the compromise of tumor-free principles during MIS\u2014particularly through the use of uterine manipulators that may cause mechanical tumor compression and dissemination.\n                      <jats:sup>3<\/jats:sup>\n                      While open surgery is generally preferred, MIS may be considered in selected cases, such as tumors \u2264 2\u00a0cm according to Chinese guidelines.\n                      <jats:sup>4<\/jats:sup>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>To address these concerns, we developed a tumor-free technique incorporating Ma\u2019s suspending band and tumor-shielded vaginal closure, adapted for robotic single-site radical hysterectomy using the da Vinci Xi platform.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Key features include: (1) ergonomic single-site access through a 3\u20134\u00a0cm umbilical incision accommodating a quad-channel port, enabling simultaneous operation of three robotic arms while preserving a dedicated assistant channel for traction, suction, and irrigation; (2) optimized pneumoperitoneum management through strategic robotic arm positioning that elevates the abdominal wall, ensuring consistent surgical exposure at reduced intra-abdominal pressures (8\u201310\u00a0mmHg versus conventional 12\u201314\u00a0mmHg); (3) minimal parietal trauma through a single-incision approach that improves cosmetic outcomes and potentially reduces port-related complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This video article details the technical execution of our procedure, highlighting its reproducibility and adherence to oncological safety principles. Prospective data collection and follow-up are ongoing to evaluate long-term oncologic outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-025-19026-6","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T16:38:58Z","timestamp":1770309538000},"page":"4765-4766","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Application of Tumor-Free Technique in Robotic Single-Site Radical Hysterectomy for Early Stage Cervical Cancer"],"prefix":"10.1245","volume":"33","author":[{"given":"Qiao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengchan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"issue":"3","key":"19026_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin."},{"issue":"23","key":"19026_CR2","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1200\/JCO.23.02335","volume":"42","author":"PT Ramirez","year":"2024","unstructured":"Ramirez PT, Robledo KP, Frumovitz M, et al. LACC trial: final analysis on overall survival comparing open versus minimally invasive radical hysterectomy for early-stage cervical cancer. J Clin Oncol. 2024;42(23):2741\u20136.","journal-title":"J Clin Oncol."},{"issue":"2","key":"19026_CR3","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.3390\/curroncol29020093","volume":"29","author":"O Touhami","year":"2022","unstructured":"Touhami O, Plante M. Minimally invasive surgery for cervical cancer in light of the LACC trial: what have we learned? Curr Oncol. 2022;29(2):1093\u2013106.","journal-title":"Curr Oncol."},{"key":"19026_CR4","unstructured":"Guidelines for diagnosis and treatment of cervical cancer. 2022. http:\/\/www.nhc.gov.cn\/cms-search\/downFiles\/361f086b71214c4e8336fa7d251dc020.pdf"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-19026-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-19026-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-19026-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T12:26:08Z","timestamp":1776255968000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-19026-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":4,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["19026"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-19026-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"18 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"This work was approved by the Institutional Review Board of West China Second University Hospital (approval no. 2023093). The patient provided written informed consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}